Hydroxyprogesterone Caproate Injection (Makena) and Risankizumab
Determining the interaction of Hydroxyprogesterone Caproate Injection (Makena) and Risankizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydroxyprogesterone
Brand name: Makena, Makena Auto-Injector, Hylutin, Delta-Lutin, Duralutin, Hyprogesterone, Prodrox
Synonyms: Hydroxyprogesterone injection, Hydroxyprogesterone Caproate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydroxyprogesterone Caproate Injection (Makena)-Risankizumab-rzaa topical
- Hydroxyprogesterone Caproate Injection (Makena)-Risedronate
- Hydroxyprogesterone Caproate Injection (Makena)-Risedronate and Calcium
- Hydroxyprogesterone Caproate Injection (Makena)-Risedronate Delayed Release
- Hydroxyprogesterone Caproate Injection (Makena)-Risedronate Delayed-Release Tablets
- Hydroxyprogesterone Caproate Injection (Makena)-Risedronate Sodium
- Risankizumab-Hydroxyprogesterone injection
- Risankizumab-Hydroxyprogesterone Intramuscular
- Risankizumab-Hydroxyquinoline vaginal
- Risankizumab-Hydroxyurea
- Risankizumab-Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Risankizumab-Hydroxyurea Capsules 500 mg